Article

Toxicological Evaluation of Ashtabhairava mathirai Acute and Subacute Safety Assessment

Raghavi Marimuthu1★, Abarna Balasubramani1★, Karpagambal Ramamoorthy1★, Suresh Ramasamy2★, Rajasri Rajaraman1★, Sathish Adithya Rajathinakaran1★, Madhavan Ramachandran1★★ Corresponding author

  1. 1Department of Nanju Maruthuvam (Siddha Toxicology), National Institute of Siddha, (Affiliated with The Tamil Nadu Dr. M. G. R Medical University), Ministry of Ayush, Chennai, Tamil Nadu, INDIA.
  2. 2Department of Gunapadam (Siddha Pharmacology), National Institute of Siddha, (Affiliated with The Tamil Nadu Dr. M. G. R Medical University), Ministry of Ayush, Chennai, Tamil Nadu, INDIA.

CORRESPONDENCE

Raghavi Marimuthu

Department of Nanju Maruthuvam (Siddha Toxicology), National Institute of Siddha (Affiliated to TN Dr. M.G.R Medical University), Ministry of Ayush, Chennai-47, Tamil Nadu, INDIA.

muthuraghavi92@gmail.com

Received: 12-02-2025; Revised: 08-04-2025; Accepted: 25-06-2025.

Volume 14, Issue 2 · pp. 314–324 · PUBLISHED May-Aug 2025 · DOI: 10.5530/ajbls.20251486

View on AJBLS original site ↗

ABSTRACT

Background/Purpose:Ashtabhairava mathirai (ABM), a traditional Siddha formulation referenced in the Siddha Vaidhiya Thirattu, is traditionally used to treat 64 types of fever. Despite its historical significance, scientific validation of its safety is crucial for its acceptance in modern medicine. This study aimed to evaluate the acute and subacute toxicity of ABM using Wistar albino rats (Rattus norvegicus). Materials and Methods:Wistar albino rats were used for acute (OECD 423) and subacute (OECD 407) toxicity studies. Behavioral, biochemical, and histopathological parameters were analyzed. Data were statistically evaluated using one-way ANOVA (p<0.05). Results:The findings of the study demonstrated that all evaluated parameters remained within normal limits, with no mortality observed throughout the experimental period. The acute oral toxicity assessment indicated that the LD50 value of Ashtabhairava mathirai (ABM) exceeds 2000 mg/kg body weight. Additionally, the repeated dose 28-day oral toxicity study determined No Observed Adverse Effect Level (NOAEL) of more than 150 mg/kg body weight. Histopathological examinations of vital organs provided further reassurance, as no abnormalities or adverse changes were noted, supporting safety of the formulation. Conclusion:These results confirm the safety of ABM for further clinical investigations but also validate its ongoing use in traditional practices. This study offers a thorough preclinical safety evaluation of ABM, providing scientific support for its traditional applications and potential as a therapeutic agent in future medical use.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Marimuthu, R., Balasubramani, A., Ramamoorthy, K., Ramasamy, S., Rajaraman, R., Rajathinakaran, S. A., & Ramachandran, M. (2025). Toxicological Evaluation of Ashtabhairava mathirai Acute and Subacute Safety Assessment. Asian Journal of Biological and Life sciences, 14(2), 314–324. https://doi.org/10.5530/ajbls.20251486